Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178711-22-000011
Filing Date
2022-08-03
Accepted
2022-08-03 16:16:02
Documents
77
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prtk-20220630.htm   iXBRL 10-Q 1495380
2 EX-31.1 prtkex-311x630202210xq.htm EX-31.1 10003
3 EX-31.2 prtkex-312x630202210xq.htm EX-31.2 9988
4 EX-32.1 prtkex-321x630202210xq.htm EX-32.1 5179
5 EX-32.2 prtkex-322x630202210xq.htm EX-32.2 5190
  Complete submission text file 0001178711-22-000011.txt   7606531

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prtk-20220630.xsd EX-101.SCH 67906
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prtk-20220630_cal.xml EX-101.CAL 57069
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prtk-20220630_def.xml EX-101.DEF 316967
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prtk-20220630_lab.xml EX-101.LAB 714705
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prtk-20220630_pre.xml EX-101.PRE 444009
71 EXTRACTED XBRL INSTANCE DOCUMENT prtk-20220630_htm.xml XML 1166099
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 221132796
SIC: 2834 Pharmaceutical Preparations